Body Mass Index Associated With the Lowest Renal Risk Across Levels of Kidney Function in Chronic Kidney Disease: A Nationwide Cohort Study
Аннотация
ABSTRACT Aim Both high and low body mass index (BMI) have been reported to be associated with a higher risk of chronic kidney disease (CKD) progression. However, whether this association varies across CKD stages remains unclear. We hypothesized that the association between BMI and renal outcomes varies according to kidney function in individuals with CKD. Methods This retrospective cohort study included individuals with an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m 2 at health checkups between April 2014 and January 2025, identified from a nationwide Japanese claims database. Cox proportional hazards models were used to examine the association between baseline BMI and a composite outcome of kidney replacement therapy initiation, a > 40% decline in eGFR from baseline or eGFR < 15 mL/min/1.73 m 2 . Restricted cubic splines were used to assess nonlinearity, and nadir BMI was defined as the BMI corresponding to the lowest risk. Results This study included 630 045 individuals. Higher hazard ratios were observed at both high and low BMI levels, although these associations were attenuated after further adjustment for eGFR and urinary protein, in addition to age, sex and comorbidities. The association between BMI and renal outcomes differed across CKD stages, and the nadir BMI was higher at lower baseline eGFR levels. Conclusion The association between BMI and renal outcomes differed across CKD stages, with a higher nadir BMI observed at lower baseline eGFR levels. These findings suggest that kidney function should be considered when interpreting BMI in individuals with CKD.